Table 1.
ApoE genotypes using rs429358 & rs7412.
Table 2.
Clinicodemographic data of participants.
Table 3.
Genotype distribution in various groups.
Table 4.
Serum lipid parameters according to ApoE variants.
Fig 1.
Distribution of lipids parameters according to ApoE genotypes.
Table 5.
Distribution of abnormal atherogenic indices among the study population stratified by diseases.
Table 6.
Distribution of abnormal atherogenic indices among ApoE allele carrier status.
Fig 2.
Distribution of lipids profile according to ApoE carrier status.
Table 7.
Univariate and multivariate analysis of atherogenic risk indices and ApoE genotypes and variants.
Fig 3.
Ten-year cardiovascular risk assessment of participants stratified by groups.
(A) QRISK3 calculator. (B) Framingham BMI risk calculator. (C) Framingham Cholesterol risk calculator.
Fig 4.
Ten-year cardiovascular risk assessment stratified by ApoE carrier status.
(A) QRISK3 calculator. (B) Framingham BMI risk calculator. (C) Framingham Cholesterol risk calculator.
Fig 5.
Ten-year cardiovascular risk assessment stratified by ApoE genotypes.
(A) QRISK3 calculator. (B) Framingham BMI risk calculator. (C) Framingham Cholesterol risk calculator.